
  Mrv0541 02231217122D          

 11 10  0  0  1  0            999 V2000
    3.9039    0.6039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9039    1.4289    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.1895    1.8414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4750    1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7605    1.8414    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4750    0.6039    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6184    1.8414    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.6184    2.6664    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3329    1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0474    1.8414    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3329    0.6039    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  2  0  0  0  0
  2  7  1  0  0  0  0
  7  8  1  1  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  2  0  0  0  0
M  END
> <DRUGBANK_ID>
DB03810

> <DRUG_GROUPS>
experimental

> <GENERIC_NAME>
(3r)-3-Methyl-L-Glutamic Acid

> <CHEMICAL_FORMULA>
C6H11NO4

> <MOLECULAR_WEIGHT>
161.1558

> <EXACT_MASS>
161.068807845

> <IUPAC_NAME>
(2R,3S)-2-amino-3-methylpentanedioic acid

> <IUPAC_TRADITIONAL_NAME>
(2R,3S)-2-amino-3-methylpentanedioic acid

> <INCHI_IDENTIFIER>
InChI=1S/C6H11NO4/c1-3(2-4(8)9)5(7)6(10)11/h3,5H,2,7H2,1H3,(H,8,9)(H,10,11)/t3-,5+/m0/s1

> <INCHI_KEY>
InChIKey=FHJNAFIJPFGZRI-WVZVXSGGSA-N

> <SMILES>
C[C@@H](CC(O)=O)[C@@H](N)C(O)=O

> <JCHEM_ACCEPTOR_COUNT>
5

> <JCHEM_DONOR_COUNT>
3

> <JCHEM_ACIDIC_PKA>
2.02

> <JCHEM_BASIC_PKA>
9.6

> <JCHEM_PHYSIOLOGICAL_CHARGE>
-1

> <ALOGPS_LOGP>
-3.3

> <JCHEM_LOGP>
-2.9

> <ALOGPS_LOGS>
-0.63

> <JCHEM_POLARIZABILITY>
14.98

> <JCHEM_POLAR_SURFACE_AREA>
100.62

> <JCHEM_REFRACTIVITY>
35.76

> <JCHEM_ROTATABLE_BOND_COUNT>
4

> <ALOGPS_SOLUBILITY>
3.81e+01 g/l __ 

$$$$
